Boosting Ferroptosis Therapy with Iridium Single‐Atom Nanocatalyst in Ultralow Metal Content
Advanced Materials · 2023
DOI: 10.1002/adma.202210037 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, 2023. Verfasst von Junjie Cheng und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry Center for Bioanalytical Chemistry, University of Science and Technology of China, Hefei, 230026, P. R. China. Hauptthemen laut MEDLINE: Ferroptosis, Neoplasms. Die Arbeit wurde bisher 98-mal zitiert (Crossref) und nennt 68 Literaturangaben. Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Nanocatalysts are promising tumor therapeutics due to their ability to induce reactive oxygen species in the tumor microenvironment. Although increasing metal loading can improve catalytic activity, the quandary of high metal content versus potential systemic biotoxicity remains challenging. Here, a fully exposed active site strategy by site‐specific anchoring of single iridium (Ir) atoms on the outer surface of a nitrogen‐doped carbon composite (Ir single‐atom catalyst (SAC)) is reported to achieve remarkable catalytic performance at ultralow metal content (≈0.11%). The Ir SAC exhibits prominent dual enzymatic activities to mimic peroxidase and glutathione peroxidase, which catalyzes the conversion of endogenous H 2 O 2 into •OH in the acidic TME and depletes glutathione (GSH) simultaneously. With an advanced support of GSH‐trapping platinum(IV) and encapsulation with a red‐blood‐cell membrane, this nanocatalytic agent (Pt@IrSAC/RBC) causes intense lipid peroxidation that boosts tumor cell ferroptosis. The Pt@IrSAC/RBC demonstrates superior therapeutic efficacy in a mouse triple‐negative mammary carcinoma model, resulting in complete tumor ablation in a single treatment session with negligible side effects. These outcomes may provide valuable insights into the design of nanocatalysts with high performance and biosafety for biomedical applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry Center for Bioanalytical Chemistry, University of Science and Technology of China, Hefei, 230026, P. R. China.
- Hefei National Research Center for Physical Sciences at Microscale, University of Science and Technology of China, Hefei, 230026, P. R. China.
- College of Pharmaceutical Sciences, Anhui Xinhua University, Hefei, 230001, P. R. China.
- Departments of Diagnostic Radiology, Surgery Chemical and Biomolecular Engineering and Biomedical Engineering, Yong Loo Lin School of Medicine and College of Design and Engineering, National University of Singapore, Sin…
- Clinical Imaging Research Centre, Centre for Translational Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117599, Singapore.
- Nanomedicine Translational Research Program, NUS Center for Nanomedicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117597, Singapore.
ORCID-Profile: Junjie Cheng, Yongfu Sun, Xiaoyuan Chen, Yangzhong Liu
Förderung
- National Key R&D Program of China
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities
- National University of Singapore
- NUS School of Medicine Nanomedicine Translational Research Programme
- National Medical Research Council
Zitieren
APA
Cheng, J., Li, L., Jin, D., Dai, Y., Zhu, Y., Zou, J., Liu, M., Yu, W., Yu, J., Sun, Y., Chen, X., & Liu, Y. (2023). Boosting Ferroptosis Therapy with Iridium Single‐Atom Nanocatalyst in Ultralow Metal Content. Advanced Materials. https://doi.org/10.1002/adma.202210037
Vancouver
Cheng J, Li L, Jin D, Dai Y, Zhu Y, Zou J, et al. Boosting Ferroptosis Therapy with Iridium Single‐Atom Nanocatalyst in Ultralow Metal Content. Advanced Materials. 2023. doi:10.1002/adma.202210037
BibTeX
@article{Cheng2023,
author = {Cheng, Junjie and Li, Li and Jin, Duo and Dai, Yi and Zhu, Yang and Zou, Jianhua and Liu, Manman and Yu, Wenxin and Yu, Jiaji and Sun, Yongfu and Chen, Xiaoyuan and Liu, Yangzhong},
title = {Boosting Ferroptosis Therapy with Iridium Single‐Atom Nanocatalyst in Ultralow Metal Content},
journal = {Advanced Materials},
year = {2023},
doi = {10.1002/adma.202210037}
}
EUVIMED